This edition of Mintz Venture Watch provides a 2024 Year in Review and an overview of VC transactions in the first half of 2025, as well as a look at Mintz’s work with clients in the technology, life sciences, and sustainable energy and infrastructure sectors.

Our Client Spotlight this month features Coworker.ai, a cool new company that has created an AI “teammate” that can perform complex work at the level of an experienced colleague.

This issue of MintzTech Connect leads with a terrific article about negotiating a letter of intent from the seller’s perspective. It continues with an article about a common problem regarding Delaware franchise taxes. The issue concludes with a spotlight on Coworker.ai, a cool new company that has created an AI “teammate” that can perform complex work at the level of an experienced colleague.

Read about Walkabout, a very interesting company with an app that aggregates everything on the internet locally, helping neighbors to connect in meaningful ways in person.

Negotiating and signing a Letter of Intent (LOI) is a key inflection point in the process of selling your business. Buyers and sellers both want the LOI to ensure a certain base level of understanding on certain key terms such as price, the structure of the deal, exclusivity, and confidentiality. However, sellers generally want, and should push for, additional details before agreeing to exclusively negotiate with a potential buyer. This article highlights key considerations for sellers to address in the LOI to protect their interests and set the stage for a successful deal.

Artificial intelligence (AI) has emerged as an influential technology, driving notable investments across various industries in recent years. In 2024, venture capital (VC) funding for AI companies reached record levels, signaling ongoing interest and optimism in the sector’s potential. Looking ahead, 2025 is anticipated to bring continued innovation, with promising funding opportunities and a growing IPO market for AI-driven businesses.

Read about Surgimatix, an early-stage medical device company pioneering the first proprietary laparoscopic device that delivers suture-like fixation in seconds.

This edition of Mintz Venture Watch reports on the firm’s VC transaction activity in the first half of 2024. During this period, Mintz represented issuers and investors in the technology, life sciences, energy, and other sectors in 73 transactions valued at more than $980 million.

Read about Radicle Science, a B-corp transforming the supplement industry’s approach to clinical trials and efficacy validation through virtual trials that greatly expand the scale and diversity of trial participants.

This edition of Mintz Venture Watch reports on the firm’s VC transaction activity in 2023. Mintz represented issuers and investors in the technology, energy, life sciences, and other sectors in more than 130 transactions valued at over $2.6 billion.